Trial Profile
Randomized, controlled trial of the effectiveness of add-on tolcapone to usual antipsychotic therapy on cognitive and negative symptoms of patients with schizophrenia genotyped for COMT polymorphisms
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 24 Oct 2014
Price :
$35
*
At a glance
- Drugs Tolcapone (Primary)
- Indications Schizophrenia and disorders with psychotic features
- Focus Therapeutic Use
- 24 Oct 2014 New trial record